| Literature DB >> 35616614 |
Antonia Katsouda1,2, Dimitrios Valakos3, Vasilios S Dionellis4, Sofia-Iris Bibli5,6, Ioannis Akoumianakis7, Sevasti Karaliota1,8, Karim Zuhra9, Ingrid Fleming5,6, Noriyuki Nagahara10, Sophia Havaki11, Vassilis G Gorgoulis3,11, Dimitris Thanos3, Charalambos Antoniades7, Csaba Szabo9, Andreas Papapetropoulos1,2.
Abstract
Given the clinical, economic, and societal impact of obesity, unraveling the mechanisms of adipose tissue expansion remains of fundamental significance. We previously showed that white adipose tissue (WAT) levels of 3-mercaptopyruvate sulfurtransferase (MPST), a mitochondrial cysteine-catabolizing enzyme that yields pyruvate and sulfide species, are downregulated in obesity. Here, we report that Mpst deletion results in fat accumulation in mice fed a high-fat diet (HFD) through transcriptional and metabolic maladaptation. Mpst-deficient mice on HFD exhibit increased body weight and inguinal WAT mass, reduced metabolic rate, and impaired glucose/insulin tolerance. At the molecular level, Mpst ablation activates HIF1α, downregulates subunits of the translocase of outer/inner membrane (TIM/TOM) complex, and impairs mitochondrial protein import. MPST deficiency suppresses the TCA cycle, oxidative phosphorylation, and fatty acid oxidation, enhancing lipid accumulation. Sulfide donor administration to obese mice reverses the HFD-induced changes. These findings reveal the significance of MPST for white adipose tissue biology and metabolic health and identify a potential new therapeutic target for obesity.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35616614 PMCID: PMC9143789 DOI: 10.1084/jem.20211894
Source DB: PubMed Journal: J Exp Med ISSN: 0022-1007 Impact factor: 17.579